BSX — Recent News Coverage
All news mentioning BSX in ESEN's AI-graded feed
News stories with BSX as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on BSX. See /coverage/BSX for the 30-day aggregate.
FINANCE.YAHOO.COM
·
2026-08-13
LOW
NEUTRAL
CORR0.58
Here’s What Hurt Boston Scientific Corporation (BSX) in Q2
$BSX
◈ ESEN AI
Boston Scientific (BSX) appears as a holding discussion within a fund manager's quarterly investor letter, a routine procedural disclosure that does not constitute a material catalyst for the stock. The article referenc…
INSIDERMONKEY.COM
·
2026-08-13
LOW
NEUTRAL
CORR0.42
Here’s What Hurt Boston Scientific Corporation (BSX) in Q2
$BSX
◈ ESEN AI
Boston Scientific (BSX) appears in TCW Funds' Q2 2026 investor letter as part of the 'TCW Concentrated Large Cap Growth Fund' portfolio review. The article references what 'hurt' the company during the quarter but provi…
SEEKINGALPHA.COM
·
2026-08-11
NEUTRAL
BULLISH
CORR0.62
Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is Overdone (NYSE:BSX)
$BSX
◈ ESEN AI
Boston Scientific reported Q2 2026 revenues of $5.4 billion, demonstrating operational resilience despite acknowledged headwinds in key product categories. The earnings result appears to have sparked a contrarian narrat…
SEEKINGALPHA.COM
·
2026-07-30
NEUTRAL
BEARISH
CORR0.42
Boston Scientific Stock: Attempting The 2027 Reset (NYSE:BSX)
$BSX
◈ ESEN AI
Boston Scientific (BSX) has reset forward guidance and publicly acknowledged heightened competitive pressures in its core medical device markets. This guidance cut signals management's recalibration of near-term expecta…
FINANCE.YAHOO.COM
·
2026-07-29
HIGH
BULLISH
CORR0.72
Boston Scientific beats second quarter expectations, raises full-year outlook
$BSX
◈ ESEN AI
Boston Scientific delivered a beat-and-raise quarter, posting adjusted EPS of $0.86 versus $0.83 consensus while simultaneously elevating full-year guidance. This dual catalyst—outperformance on both the top and bottom …
SEEKINGALPHA.COM
·
2026-07-29
NEUTRAL
NEUTRAL
CORR0.42
Boston Scientific Corporation (BSX) Q2 2026 Earnings Call Transcript
$BSX
◈ ESEN AI
Boston Scientific (BSX) released Q2 2026 earnings results via earnings call on July 29, 2026. The earnings call transcript alone, without disclosed financial results or forward guidance, provides limited directional cla…
RTTNEWS.COM
·
2026-07-29
HIGH
BEARISH
CORR0.58
Boston Scientific Trims FY26 Outlook - Update
$BSX
◈ ESEN AI
Boston Scientific Corp. (BSX) has reduced its full-year 2026 earnings and revenue guidance following second-quarter results, signaling management confidence deterioration and potential headwinds in the medical devices s…
FINANCE.YAHOO.COM
·
2026-07-28
NEUTRAL
BEARISH
CORR0.35
Boston Scientific expects headcount reductions amid restructuring initiative
$BSX
◈ ESEN AI
Boston Scientific has initiated a restructuring program with material near-term cost implications. The $700–800 million charge signals operational challenges requiring workforce optimization, though the multi-year timel…
MANILATIMES.NET
·
2026-07-14
NEUTRAL
BULLISH
CORR0.42
ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board
$MDT
$BSX
◈ ESEN AI
ViCentra, a European medical device innovator focused on insulin delivery systems, has appointed Ian Wells as Chief Financial Officer and added medtech M&A veteran Tom West to its board. Wells brings substantial P&L man…
SEEKINGALPHA.COM
·
2026-07-06
NEUTRAL
NEUTRAL
CORR0.42
Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX)
$BSX
◈ ESEN AI
Boston Scientific (BSX) is trading approximately 60% below recent highs, presenting a valuation reset in the medical device sector. This magnitude of drawdown typically reflects either cyclical sector rotation, company-…
FINANCE.YAHOO.COM
·
2026-06-25
NEUTRAL
BULLISH
CORR0.52
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX)
$BSX
◈ ESEN AI
Boston Scientific (BSX) has experienced significant sell-off pressure year-to-date, declining over 52%, yet maintains analyst conviction through maintained Buy ratings from institutional research teams. TD Cowen's reite…
FINANCE.YAHOO.COM
·
2026-06-23
NEUTRAL
BULLISH
CORR0.42
Piper Sandler Maintains Overweight Rating for Boston Scientific (BSX)
$BSX
◈ ESEN AI
Boston Scientific (BSX) has been identified as an oversold medical device stock with substantial recovery potential despite a June 12 target price reduction from Piper Sandler. The 28% downward revision to $65 paradoxic…
FINANCE.YAHOO.COM
·
2026-06-22
NEUTRAL
BEARISH
CORR0.35
Truist Cuts Boston Scientific (BSX) ’s Target as Doctors Change How They Use Its Heart Device
$BSX
◈ ESEN AI
Boston Scientific (BSX) faces a notable headwind as Truist Securities reduced its price target by 24.7%, from $85 to $64, while maintaining a Buy rating. This mixed messaging—downside revision paired with bullish stance…
FINANCE.YAHOO.COM
·
2026-06-17
NEUTRAL
BEARISH
CORR0.72
Below Expected Outlook Pressured Boston Scientific (BSX) in Q1
$BSX
◈ ESEN AI
Boston Scientific (BSX) faced downward pressure in Q1 2026 following a below-expected forward guidance, reflecting broader large-cap growth weakness during the period. The medical device manufacturer's cautious outlook …
FINANCE.YAHOO.COM
·
2026-06-11
NEUTRAL
BULLISH
CORR0.58
BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock
$BSX
◈ ESEN AI
Boston Scientific (BSX) has experienced substantial de-rating in 2026, trading down nearly 50% year-to-date as of June. Despite this sharp decline, BTIG maintains a bullish stance, suggesting the market may have oversho…
EXPLORE OTHER FILTERS